¿Pueden las farmacéuticas chinas desarrollar fármacos innovadores contra el cáncer? 🇨🇳💊
3 terapias de BeiGene:
💊 Zanubrutinib
💉 Tislelizumab
🧬 Pamiparib
🎥 Mira el video para conocer más.
#BeiGene #ChinesePharma #CancerTherapy #Oncology #DengYueMed
BeiGene shares dropped 12% pre-market on Sept 10
The selloff came after reports that Trump’s team is considering an executive order targeting Chinese pharmaceutical imports. Investors are bracing for potential disruptions to global drug supply chains.
#BeiGene #Biotech #ChinaPharma #DrugPolicy
As part of its continued partnership with #BeiGene, we have launched a newly curated collection of educational resources on #cancer, building on resources developed since 2023. Read more here 👇
#cancercare #pharmacyCPD
nference and BeiGene Join Forces to Enhance B-Cell Cancer Treatment Insights #USA #Cambridge #CLL #nference #BeiGene
Chronic lymphocytic leukaemia: diagnosis and management
An overview of how to diagnose, manage and monitor patients with #CLL, emphasising the important role of pharmacists.
(Supported by #BeiGene)
#cancercare
Our latest CPD article, supported by #BeiGene, provides an overview of how to diagnose, manage and monitor patients with chronic lymphocytic leukaemia, emphasising the important role of pharmacists
#CLL #pharmacyCPD
#BeiGene , azienda oncologica globale, ha annunciato la nomina di Giancarlo Benelli a Senior Vice President e Head of Europe, con decorrenza dal 1° gennaio 2025.
wp.me/p7CsDE-27U
#pharma #MPBnews
www.linkedin.com/pulse/beigen...
BeiGene's $150M Deal with CSPC Zhongqi: A Bold Move to Compete with Amgen in Cancer Drug Combinations
kstrategyand.com/pharma-news
#BeiGene #CSPC #CancerResearch #Oncology #PRMT5 #DrugCombination #InnovationInHealthcare #Humanteconomy #Humantec #KStrategyand